Video

Neilanjan Nandi from Drexel University College of Medicine: An Exciting Time in Crohn's Disease Treatment

Author(s):

As the treatment for Crohn's disease moves away from steroids and surgery and towards less severe and more effective medications patients with the condition can look forward to a higher quality of life than they had in the past.

As the treatment for Crohn's disease moves away from steroids and surgery and towards less severe and more effective medications patients with the condition can look forward to a higher quality of life than they had in the past.

Neilanjan Nandi, MD, from the Drexel University College of Medicine discussed some of the advancements in treatment of the condition and what it can mean to overall patient care during a recent interview with MD Magazine. Nandi said that because surgery and steroids have their own independent risks it is beneficial to patients and doctors to have these alternative treatment methods to turn to.

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Satish Rao, MD, PhD | Credit: ACG
Anthony Kerbage, MD | Credit: ResearchGate
© 2024 MJH Life Sciences

All rights reserved.